Related Experiment Videos
Radiation associated hyperthyroidism in patients with gynecological malignancies
Journal of Medicine
|January 1, 1985
Summary
Gynecological cancer radiation therapy, particularly to the abdomen and pelvis, significantly increases the risk of developing hyperthyroidism later. This study found a notable rise in hyperthyroidism cases among patients receiving such treatments.
Area of Science:
- Endocrinology
- Oncology
- Radiation Oncology
Background:
- Gynecological malignancies require treatments like radiation therapy.
- Abdominal and pelvic irradiation are common therapeutic approaches.
- Potential long-term side effects of radiation exposure require investigation.
Purpose of the Study:
- To assess the association between abdominal/pelvic irradiation for gynecological cancers and the subsequent development of hyperthyroidism.
- To quantify the risk of hyperthyroidism following radiation treatment in this patient cohort.
Main Methods:
- Retrospective review of 1,884 medical records of patients diagnosed with cervical, uterine, or ovarian cancer.
- Comparison of hyperthyroidism incidence in 1,269 patients who received radiation therapy versus 581 who did not.
- Estimation of radiation doses to the thyroid gland in affected patients.
Main Results:
- Five patients who received abdominal and/or pelvic irradiation developed hyperthyroidism, a statistically significant increase compared to epidemiological data.
- The estimated radiation dose to the thyroid ranged from 30 to 200 rads.
- No hyperthyroidism cases were observed in the 581 patients who did not receive radiation therapy.
Conclusions:
- Radiation therapy for gynecological malignancies, specifically involving the abdomen and pelvis, leads to significant thyroid radiation exposure.
- This exposure is associated with a statistically significant increased incidence of subsequent hyperthyroidism.
- Clinical monitoring for thyroid dysfunction is warranted in patients treated with pelvic or abdominal radiation.